Publications réalisées lors de l'ASCO (American Society Of Clinical Oncology)


A safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of the head and neck (R/M SCCHN): Interim analysis on 199 patients—The TOPNIVO study on behalf of the GORTEC and the Unicancer Head & Neck Group.

Caroline Even, Amaury Daste, Esma Saada-Bouzid, Gautier Lefebvre, Jerome Fayette, Sylvie Zanetta, Marie-Christine Kaminsky, Didier Cupissol, Alain Prevost, Elodie Vauleon, Alison Claire Johnson, Sebastien Salas, Frederic Rolland, Miruna Timar David, Isabelle Jallut, Jessy Delaye, Jean Bourhis, Joel Guigay, Matthieu Texier, Anne Auperin

J Clin Oncol 37, 2019 (suppl; abstr 6032)